Information: 020 7427 6087
IncontiLase® is a patent-pending, non-invasive Er:YAG laser therapy for the treatment of mild and moderate stress urinary incontinence. The treatment is based on non-ablative photothermal stimulation of collagen neogenesis, the shrinking and tightening of vaginal mucosa tissue and collagen-rich endopelvic fascia, which subsequently gives greater support to the bladder.
The indications for IncontiLase therapy are mild and moderate stress and mixed-urinary incontinence (SUI). Preliminary clinical studies show it’s an efficient, safe and easy-to-perform procedure.
Fotona’s 2940 nm Er:YAG non-ablative laser thermally affects the vaginal tissue, stimulating collagen remodeling and the synthesis of new collagen fibres in the vestibule and urethral orifice, and the area along the anterior vaginal wall.
The final result is the shrinking and tightening of vaginal mucosa tissue and collagen-rich endopelvic fascia, and subsequently greater support to the bladder and the return of normal continence function.
The Fotona Smooth XS is a multi treatment, easy-to-use laser system for all gynecology needs. The system features Er:YAG laser technology; ideal for the treatment of stress urinary incontinence (IncontiLase), vaginal relaxation syndrome (IntimaLase) genitourinary syndrome of menopause (RenovaLase), prolapse (ProlapLase) as well as lesions of the uterine neck and vagina, HPV lesions, pigmentations and neoplasias.
An incisionless and virtually painless treatment
No ablation, cutting or bleeding
Extremely quick recovery time
Strong painkillers or antibiotics are not required
No special pre-op prep or post-op precautions
Immediately return normal everyday activities
Scientific results from clinical studies show excellent improvement for mild and moderate stress urinary incontinence from the IncontiLase® treatment method. Key findings include:
For more reading on the clinical science behind IncontiLase, we recommend the key research papers linked below.
You can also head to the Knowledge Base section of our site, or check out Key Events to join the latest seminars and demonstrations run by leading laser experts.
Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study – Read Full Text. Gaspar, A., Maestri, S., Silva J., Brandi H., Luque D., Koron N., Vižintin Z. Lasers in Surgery and Medicine. 2018
Non-ablative Er:YAG Laser Therapy Effect on Stress Urinary Incontinence Related to Quality of Life and Sexual Function: A Randomized Controlled Trial – Read Full Text. Blaganje, M., Šćepanović, D., Žgur, L., Verdenik, I., Pajk, F., Lukanović, A. European Journal of Obstetrics & Gynecology and Reproductive Biology 224 (2018):153–158
Baseline ICIQ-UI score, body mass index, age, average birth weight, and perineometry duration as promising predictors of the short-term efficacy of Er:YAG laser treatment in stress urinary incontinent women: A prospective cohort study – Read Full Text. Fistonić, I. & Fistonić, N. Lasers in Surgery and Medicine. 2018
Additional Resources: visit the Laser and Health Academy website for additional information about medical laser treatments that can be performed with Fotona laser systems.Book a Call Back